Ryan White HIV/AIDS Program Performance Measures: How Do I Choose from so Many Options?
In-depth review of Policy Clarification Notice 15-02 requirements for performance measurement.
Resource (Conference Presentation) updated 09/14/2023
In-depth review of Policy Clarification Notice 15-02 requirements for performance measurement.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 09/19/2023
Resource updated 04/16/2024
Resource from the RWHAP Best Practices Compilation updated on 02/28/2024
Resource updated 09/19/2023
Resource updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 04/15/2024
The syndemic of opioid use disorder, HCV and HIV and stigma causes burdens on individuals and the system. Integrating siloed systems of care is critical to addressing this crisis. Overlapping cascades of care are key to understanding the empirical relationships of these diseases and opportunities to identify, prevent and co-treat.
Resource (Conference Presentation) updated 09/14/2023
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
Overview of HRSA HAB work to develop three electronic clinical quality measures (eCQMs) focused on HIV care.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 06/27/2024
Resource updated 10/10/2023
Resource from the RWHAP Best Practices Compilation updated on 11/27/2023
Resource updated 06/27/2024
Resource updated 10/31/2023
Resource updated 01/29/2024